These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30585922)

  • 1. Characteristics and Outcomes of Full-thickness Macular Hole Repair in Patients Receiving Anti-VEGF Injections for Neovascular Age-related Macular Degeneration.
    Ringeisen AL; Parke DW; Dev S
    Int Ophthalmol Clin; 2019; 59(1):127-135. PubMed ID: 30585922
    [No Abstract]   [Full Text] [Related]  

  • 2. RANIBIZUMAB AND AFLIBERCEPT FOR THE TREATMENT OF PIGMENT EPITHELIAL DETACHMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Data from an Observational Study.
    Vaze A; Nguyen V; Daien V; Arnold JJ; Young SH; Cheung CM; Lamoureux E; Bhargava M; Barthelmes D; Gillies MC;
    Retina; 2018 Oct; 38(10):1954-1961. PubMed ID: 28820848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH ADVANCED VISUAL LOSS TREATED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY: Clinical Outcome and Prognostic Indicators.
    Vogel RN; Davis DB; Kimura BH; Rathinavelu S; Graves GS; Szabo A; Han DP
    Retina; 2017 Feb; 37(2):257-264. PubMed ID: 27429385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMOKING STATUS AND TREATMENT OUTCOMES OF VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Vittorio AF; Nguyen V; Barthelmes D; Arnold JJ; Cheung CMG; Murray N; Gillies MC;
    Retina; 2020 Sep; 40(9):1696-1703. PubMed ID: 31613840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses of Types 1 and 2 Neovascularization in Age-Related Macular Degeneration to Anti-Vascular Endothelial Growth Factor Treatment: Optical Coherence Tomography Angiography Analysis.
    Kim JM; Cho HJ; Kim Y; Jung SH; Lee DW; Kim JW
    Semin Ophthalmol; 2019; 34(3):168-176. PubMed ID: 31132283
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictability of Recalcitrance in Neovascular Age-Related Macular Degeneration With Indocyanine Green Angiography.
    Rush RB; Rush SW
    Asia Pac J Ophthalmol (Phila); 2015; 4(4):187-90. PubMed ID: 26147016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAVING SIGHT IN NEOVASCULAR AMD.
    Retina; 2020 Jul; 40 Suppl 2():S1-S12. PubMed ID: 32558673
    [No Abstract]   [Full Text] [Related]  

  • 8. PREDICTORS OF ONE-YEAR VISUAL OUTCOMES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Kodjikian L; Decullier E; Souied EH; Roux A; Aulagner G; Huot L;
    Retina; 2018 Aug; 38(8):1492-1499. PubMed ID: 28654629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends of Anti-Vascular Endothelial Growth Factor Use in Ophthalmology Among Privately Insured and Medicare Advantage Patients.
    Parikh R; Ross JS; Sangaralingham LR; Adelman RA; Shah ND; Barkmeier AJ
    Ophthalmology; 2017 Mar; 124(3):352-358. PubMed ID: 27890437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INTRAVITREAL AFLIBERCEPT FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION UNRESPONSIVE TO RANIBIZUMAB THERAPY.
    Sarao V; Parravano M; Veritti D; Arias L; Varano M; Lanzetta P
    Retina; 2016 Apr; 36(4):770-7. PubMed ID: 26398691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching between ranibizumab and aflibercept for the treatment of neovascular age-related macular degeneration.
    Mantel I; Gillies MC; Souied EH
    Surv Ophthalmol; 2018; 63(5):638-645. PubMed ID: 29476754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Outcomes of Ranibizumab versus Aflibercept for Neovascular Age-Related Macular Degeneration: Data from the Fight Retinal Blindness! Registry.
    Bhandari S; Nguyen V; Arnold J; Young S; Banerjee G; Gillies M; Barthelmes D
    Ophthalmology; 2020 Mar; 127(3):369-376. PubMed ID: 31757494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TYPE 2 (SUBRETINAL) NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION ASSOCIATED WITH PURE RETICULAR PSEUDODRUSEN PHENOTYPE.
    Naysan J; Jung JJ; Dansingani KK; Balaratnasingam C; Freund KB
    Retina; 2016 Mar; 36(3):449-57. PubMed ID: 26383711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GOOD VISUAL OUTCOME AT 1 YEAR IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH PIGMENT EPITHELIUM DETACHMENT: Factors Influencing the Treatment Response.
    de Massougnes S; Dirani A; Mantel I
    Retina; 2018 Apr; 38(4):717-724. PubMed ID: 28368974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical coherence tomography angiography of type 3 neovascularisation in age-related macular degeneration after antiangiogenic therapy.
    Phasukkijwatana N; Tan ACS; Chen X; Freund KB; Sarraf D
    Br J Ophthalmol; 2017 May; 101(5):597-602. PubMed ID: 27503396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights From Survival Analyses During 12 Years of Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration.
    Fu DJ; Keenan TD; Faes L; Lim E; Wagner SK; Moraes G; Huemer J; Kern C; Patel PJ; Balaskas K; Sim DA; Bunce C; Stratton I; Keane PA
    JAMA Ophthalmol; 2021 Jan; 139(1):57-67. PubMed ID: 33211064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and characteristics of macular atrophy in eyes with neovascular age-related macular degeneration. A study from a long-term observational dataset: the Fight Retinal Blindness! project.
    Daien V; Nguyen V; Essex RW; Guymer R; Arnold JJ; Munk M; Ceklic L; Gillies MC; Barthelmes D;
    Br J Ophthalmol; 2020 Aug; 104(8):1064-1069. PubMed ID: 31843790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization.
    Sayanagi K; Uematsu S; Hara C; Wakabayashi T; Fukushima Y; Sato S; Ikuno Y; Nishida K
    Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):749-757. PubMed ID: 30643966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration: a meta-analysis of randomized controlled trials.
    Nguyen CL; Oh LJ; Wong E; Wei J; Chilov M
    BMC Ophthalmol; 2018 May; 18(1):130. PubMed ID: 29843663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration: A Report by the American Academy of Ophthalmology.
    Bakri SJ; Thorne JE; Ho AC; Ehlers JP; Schoenberger SD; Yeh S; Kim SJ
    Ophthalmology; 2019 Jan; 126(1):55-63. PubMed ID: 30077616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.